Horse tranquiliser trial is awarded $750,000 grant for Parkinson’s research

News

Author: Simge Eva DoganPublished: 26 July 2018

Parkinson's LifePrep: Parkinson's LifeCook: Parkinson's LifeServes:

ketamine

Researchers at the University of Arizona College of Medicine, Tucson, US, will be trialling ketamine – a recreational drug previously used to medicate people with depression – as a treatment for Parkinson’s.

The research – led by Dr Scott Sherman – is being supported with a three-year grant of $750,000 from the Arizona Biomedical Research Commission.

The initial clinical trial will test the effect of ketamine for treating dyskinesia in 10 patients. In addition, the researchers will carry out a separate rodent study to examine how the drug affects the brain.

Dr Scott Sherman, a neurologist at the University of Arizona College of Medicine, said: “Ketamine has been long overlooked. Now it could prove very useful for Parkinson’s patients.”

For information on the latest Parkinson’s research please visit the European Parkinson’s Disease Association website.

For more information on this article click here.

Go Back

Share this story

Comments


Related articles


QUOTES-ORANGE

Perspectives

Who said what: QoTW 28.05.15

Our favourite quotes of the week from around the web

READ MORE
In the factory

Resources & Tools

Michael J Fox Foundation releases online resources for handling Parkinson’s in the workplace

The downloadable guides include tips on disclosing diagnoses

READ MORE
December 2015 Events Voices of Hope choir

Agenda

December 2015

Highlights: Dublin Voices of Hope Choir & neuroscience conference

READ MORE